{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T10:19:01Z","timestamp":1769336341144,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.clinbiochem.2011.01.009","type":"journal-article","created":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T04:33:40Z","timestamp":1296621220000},"page":"435-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Guido","family":"Filler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Han Susan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Casier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luan A.","family":"Chau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Madrenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2011.01.009_bb0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.clinbiochem.2011.01.009_bb0010","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinbiochem.2011.01.009_bb0015","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1093\/ndt\/gfm347","article-title":"Regulation of fibroblast growth factor-23 in chronic kidney disease","volume":"22","author":"Westerberg","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinbiochem.2011.01.009_bb0020","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/clinchem\/43.6.1077","article-title":"Are cystatin C and beta 2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects?","volume":"43","author":"Filler","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2011.01.009_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2004.09.025","article-title":"Cystatin C as a marker of GFR\u2014history, indications, and future research","volume":"38","author":"Filler","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2011.01.009_bb0030","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2011.01.009_bb0035","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00467-003-1271-5","article-title":"Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula?","volume":"18","author":"Filler","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinbiochem.2011.01.009_bb0040","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/ndt\/gfp699","article-title":"Fibroblast growth-23 and early decrements in kidney function: the Heart and Soul Study","volume":"25","author":"Ix","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinbiochem.2011.01.009_bb0045","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2215\/CJN.08241109","article-title":"Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism","volume":"5","author":"Evenepoel","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clinbiochem.2011.01.009_bb0050","article-title":"Hyperfiltration affects accuracy of creatinine eGFR measurement","author":"Huang","year":"2010","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912011000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912011000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:33:40Z","timestamp":1757864020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912011000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":10,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0009912011000373"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.01.009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}